MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in cash, cash
equivalents and restricted...
-$41,820K
Proceeds from the
exercise of stock options
$157K
Net income
$37,032K
Adjustment for excess and
obsolete inventories
-$15,353K
Depreciation and
amortization
$15,273K
Stock-based compensation
$13,298K
Write-down to fair value for
asset held for sale...
$11,175K
Accrued expenses and
other current...
$10,381K
Deferred tax expense
(benefit)
$9,500K
Reduction in the carrying
value of right-of-use...
$8,342K
Provision recorded for
credit losses
$8,213K
Amortization of intangible
assets
$3,323K
Non-cash interest
expense
$375K
Loss on disposal of
property and equipment
-$188K
Other liabilities
$158K
Net cash provided by
(used in) financing...
-$17,360K
Net cash used in
investing activities
-$14,151K
Net cash provided by
(used in) operating...
-$10,309K
Canceled cashflow
$157K
Canceled cashflow
$132,611K
Construction of landlord
assets, net of tenant...
$14,461K
Payments of withholding
taxes in connection...
$1,885K
Principal repayments of
finance lease...
$1,171K
Purchases of property and
equipment
$14,151K
Accounts receivable
$115,803K
Inventories
$17,915K
Operating leases
$8,491K
Accounts payable
-$528K
Prepaid expenses and
other current and...
$183K
Back
Back
Cash Flow
source: myfinsight.com
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)